Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

Patients with MS who discontinued injectable DMT after a long period of relapse freedom had a similar relapse rate as propensity score-matched patients who continued on DMT, but higher hazard for disability progression.